1. To provide guidance to the
manufacturer in addressing critical issues related to specimen integrity specific to
the type of testing to be performed, eg, bacterial and viral culture, or nucleic acid
detection. The M40 document focuses on the methods for quality control testing and acceptance criteria to provide a product suitable for analysis of clinical specimens for agents of disease. Specific Expertise/Work Experience Needed:
Submit your notification of interest along with a curriculum vitae through our website.
The deadline to submit your notification in serving on the subcommittee is 29 May 2009.
Upon receipt of your statement of interest in serving on the subcommittee, a
disclosure of interests form will be sent to you for completion.
Questions? Please contact Donna Connery at dconnery@clsi .org
2. Description:
The intent of the proposed guideline is to help laboratorians determine which analytes are the most efficient to use for delta checking and to give practical guidance for determining optimal limits derived from the user institution’s patient population. Guidance will also be provided for defining appropriate follow-up for delta check failures. Precautions and practices to avoid will be included.
Due Date: 29 May 2009